TNFSF11 Gene Osteopetrosis Autosomal Recessive Type 2 Genetic Test
At DNA Labs UAE, we offer the TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test. This test is designed to analyze the TNFSF11 gene for mutations associated with autosomal recessive type 2 osteopetrosis. Osteopetrosis is a rare genetic disorder characterized by increased bone density and abnormal bone growth.
Test Components and Price
The TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA Card.
Report Delivery
The report for the TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test is typically delivered within 3 to 4 weeks.
Method and Test Type
The TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test utilizes Next-Generation Sequencing (NGS) technology to analyze the TNFSF11 gene for mutations. This test falls under the categories of Osteology, Dermatology, and Immunology Disorders.
Doctor and Test Department
The TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test is performed by a Dermatologist in the Genetics department.
Pre Test Information
Prior to undergoing the TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test, it is recommended to provide the clinical history of the patient. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with TNFSF11 Gene Osteopetrosis, autosomal recessive type 2 NGS Genetic DNA Test gene TNFSF11.
Test Details
The TNFSF11 gene osteopetrosis, autosomal recessive type 2 NGS genetic test is a genetic test that analyzes the TNFSF11 gene for mutations associated with autosomal recessive type 2 osteopetrosis. The TNFSF11 gene is responsible for producing a protein called RANK ligand, which is involved in the regulation of bone remodeling and the differentiation and activation of osteoclasts.
The NGS genetic test for TNFSF11 gene osteopetrosis analyzes the entire coding region of the TNFSF11 gene to identify any mutations or genetic variants that may be associated with the condition. This test can help confirm a diagnosis of autosomal recessive type 2 osteopetrosis and provide information about the specific genetic variant(s) present in an individual.
The results of the test can be used to guide treatment decisions and management strategies for individuals with osteopetrosis. They can also provide information about the risk of passing on the condition to future generations and help with genetic counseling and family planning.
It is important to note that genetic testing for TNFSF11 gene osteopetrosis should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.
| Test Name | TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TNFSF11 Gene Osteopetrosis, autosomal recessive type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TNFSF11 Gene Osteopetrosis, autosomal recessive type 2 NGS Genetic DNA Test gene TNFSF11 |
| Test Details |
TNFSF11 gene osteopetrosis, autosomal recessive type 2 NGS genetic test is a genetic test that uses Next-Generation Sequencing (NGS) technology to analyze the TNFSF11 gene for mutations associated with autosomal recessive type 2 osteopetrosis. Osteopetrosis is a rare genetic disorder characterized by increased bone density and abnormal bone growth. Autosomal recessive type 2 osteopetrosis is caused by mutations in the TNFSF11 gene, which is responsible for producing a protein called RANK ligand. This protein is involved in the regulation of bone remodeling and the differentiation and activation of osteoclasts, which are cells responsible for breaking down and resorbing bone tissue. The NGS genetic test for TNFSF11 gene osteopetrosis analyzes the entire coding region of the TNFSF11 gene to identify any mutations or genetic variants that may be associated with the condition. This test can help confirm a diagnosis of autosomal recessive type 2 osteopetrosis and provide information about the specific genetic variant(s) present in an individual. The results of the test can be used to guide treatment decisions and management strategies for individuals with osteopetrosis. They can also provide information about the risk of passing on the condition to future generations and help with genetic counseling and family planning. It is important to note that genetic testing for TNFSF11 gene osteopetrosis should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support. |
